Kalnik Matthew W. 4
4 · NABI BIOPHARMACEUTICALS · Filed Mar 17, 2010
Insider Transaction Report
Form 4
Kalnik Matthew W.
SVP Strategic Plan. & Bus. Ops
Transactions
- Sale
Common Stock
2010-03-17$5.93/sh−9,873$58,547→ 29,650.104 total
4 · NABI BIOPHARMACEUTICALS · Filed Mar 17, 2010
Common Stock